Breaking News

Novartis Selects PharmaVentures for Horsham Site Options

Will look to reuse part of the site as a science or business park

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novartis has selected PharmaVentures as advisors to address options for its UK Horsham site. In February, Novartis announced plans to close the Horsham site following a global review of its research operations.   Options for the site could include reusing part of the site as a science or business park. PharmaVentures will provide advice on this possibility and will help identify potential partners.   Dr. Fintan Walton, chief executive officer of PharmaVentures, said, “The Novartis Horsham ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters